OSE Immunotherapeutics Competitors and Similar CompaniesClear all

OSE Immunotherapeutics's competitors and similar companies include APEIRON Biologics, Janssen, Achilles Therapeutics and Italfarmaco.

	OSE Immunotherapeutics OSE Immunotherapeutics is a biotechnology company that focuses on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases.	APEIRON Biologics APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.	Janssen Janssen is a company providing prescription pharmaceutical products.	Achilles Therapeutics Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.	Italfarmaco Italfarmaco is a pharmaceutical company providing products in the cardiovascular, immuno-oncologic, and gynecological areas.
Founding Date	Founding Date 2012	Founding Date 2005	Founding Date 1953	Founding Date 2016	Founding Date 1938
Type	Type Public	Type Private	Type Subsidiary	Type Private	Type Private
Tags	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech clinical research drug development medical records oncology therapy	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma
Locations	Locations Nantes, FR HQ Paris, FR	Locations Wien, AT HQ	Locations Raritan, US HQ Vienna, AT Prague, CZ Espoo, FI Budapest, HU Oslo, NO Belgrade, RS see more	Locations London, GB HQ Stevenage, GB	Locations Cinisello Balsamo, IT HQ Paleo Faliro, GR Milano, IT Algés, PT Moskva, RU Alcobendas, ES Berwyn, US
Employees	Employees 52	Employees 5	Employees 17,3684% decrease	Employees 695% decrease	Employees 3,043
Financial
Net income	Net income €37.4m (FY, 2024)	Net income N/A	Net income N/A	Net income ($69.7m) (FY, 2023)	Net income N/A
Funding
Total funding raised	Total funding raised $ 10.3m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 138.1m	Total funding raised N/A